HU169073B - - Google Patents

Info

Publication number
HU169073B
HU169073B HUGO1272A HUGO001272A HU169073B HU 169073 B HU169073 B HU 169073B HU GO1272 A HUGO1272 A HU GO1272A HU GO001272 A HUGO001272 A HU GO001272A HU 169073 B HU169073 B HU 169073B
Authority
HU
Hungary
Application number
HUGO1272A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to HUGO1272A priority Critical patent/HU169073B/hu
Priority to AT386375A priority patent/AT346501B/de
Priority to US05/579,979 priority patent/US4005089A/en
Priority to AU81425/75A priority patent/AU495690B2/en
Priority to GB2283775A priority patent/GB1474337A/en
Priority to YU01355/75A priority patent/YU135575A/xx
Priority to IL47361A priority patent/IL47361A/xx
Priority to DD186250A priority patent/DD121639A5/xx
Priority to SE7505974A priority patent/SE419548B/xx
Priority to BG030088A priority patent/BG27374A3/xx
Priority to FI751537A priority patent/FI61897C/fi
Priority to BE156729A priority patent/BE829518A/xx
Priority to PL1975180710A priority patent/PL98944B1/pl
Priority to CA227,849A priority patent/CA1051878A/en
Priority to DK235175A priority patent/DK143801C/da
Priority to FR7516377A priority patent/FR2272671B1/fr
Priority to SU752144199A priority patent/SU625612A3/ru
Priority to NL7506276A priority patent/NL7506276A/xx
Priority to DE19752523743 priority patent/DE2523743A1/de
Priority to ES437994A priority patent/ES437994A1/es
Priority to JP50063984A priority patent/JPS5218718B2/ja
Priority to CS753741A priority patent/CS194227B2/cs
Publication of HU169073B publication Critical patent/HU169073B/hu
Priority to US05/749,398 priority patent/US4064249A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUGO1272A 1974-05-28 1974-05-28 HU169073B (enExample)

Priority Applications (23)

Application Number Priority Date Filing Date Title
HUGO1272A HU169073B (enExample) 1974-05-28 1974-05-28
AT386375A AT346501B (de) 1974-05-28 1975-05-21 Verfahren zur herstellung von neuen verbindungen mit ergolin-struktur
US05/579,979 US4005089A (en) 1974-05-28 1975-05-22 Compounds with ergoline skeleton
AU81425/75A AU495690B2 (en) 1974-05-28 1975-05-22 New compounds with ergoline skeleton anda process forthe preparation thereof
GB2283775A GB1474337A (en) 1974-05-28 1975-05-23 Run-flat pneumatic tyre and wheel assembly
YU01355/75A YU135575A (en) 1974-05-28 1975-05-25 Process for obtsining new compounds of the ergoline structure
IL47361A IL47361A (en) 1974-05-28 1975-05-26 8b-substituted-6-methyl ergoline derivatives and a process for the preparation thereof
DD186250A DD121639A5 (enExample) 1974-05-28 1975-05-26
SE7505974A SE419548B (sv) 1974-05-28 1975-05-26 Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat
BG030088A BG27374A3 (bg) 1974-05-28 1975-05-26 Метод за получаване на съединения с ерголинова структура
BE156729A BE829518A (fr) 1974-05-28 1975-05-27 Nouveaux composes comportant un squelette d'ergoline, leur procede de preparation et medicaments les contenant
FI751537A FI61897C (fi) 1974-05-28 1975-05-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav
PL1975180710A PL98944B1 (pl) 1974-05-28 1975-05-27 Sposob wytwarzania nowych zwiazkow o strukturze ergoliny
CA227,849A CA1051878A (en) 1974-05-28 1975-05-27 Compounds with ergoline skeleton and a process for the preparation thereof
DK235175A DK143801C (da) 1974-05-28 1975-05-27 Analogifremgangsmaade til fremstilling af dihydrolysergsyrederivater
FR7516377A FR2272671B1 (enExample) 1974-05-28 1975-05-27
SU752144199A SU625612A3 (ru) 1974-05-28 1975-05-27 Способ получени эрголиновых соединений или их солей
NL7506276A NL7506276A (nl) 1974-05-28 1975-05-28 Werkwijze voor de bereiding van nieuwe ergolineder- ivaten.
DE19752523743 DE2523743A1 (de) 1974-05-28 1975-05-28 Verbindungen mit ergolinstruktur, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
ES437994A ES437994A1 (es) 1974-05-28 1975-05-28 Procedimiento para preparar compuestos con esqueleto de er- golina.
JP50063984A JPS5218718B2 (enExample) 1974-05-28 1975-05-28
CS753741A CS194227B2 (en) 1974-05-28 1975-05-28 Method of producing derivatives of lysergic acid amide
US05/749,398 US4064249A (en) 1974-05-28 1976-12-10 Compounds with ergoline skeleton

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO1272A HU169073B (enExample) 1974-05-28 1974-05-28

Publications (1)

Publication Number Publication Date
HU169073B true HU169073B (enExample) 1976-09-28

Family

ID=10996767

Family Applications (1)

Application Number Title Priority Date Filing Date
HUGO1272A HU169073B (enExample) 1974-05-28 1974-05-28

Country Status (21)

Country Link
US (1) US4005089A (enExample)
JP (1) JPS5218718B2 (enExample)
AT (1) AT346501B (enExample)
BE (1) BE829518A (enExample)
BG (1) BG27374A3 (enExample)
CA (1) CA1051878A (enExample)
CS (1) CS194227B2 (enExample)
DD (1) DD121639A5 (enExample)
DE (1) DE2523743A1 (enExample)
DK (1) DK143801C (enExample)
ES (1) ES437994A1 (enExample)
FI (1) FI61897C (enExample)
FR (1) FR2272671B1 (enExample)
GB (1) GB1474337A (enExample)
HU (1) HU169073B (enExample)
IL (1) IL47361A (enExample)
NL (1) NL7506276A (enExample)
PL (1) PL98944B1 (enExample)
SE (1) SE419548B (enExample)
SU (1) SU625612A3 (enExample)
YU (1) YU135575A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064249A (en) * 1974-05-28 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Compounds with ergoline skeleton
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
HU172479B (hu) * 1976-03-09 1978-09-28 Gyogyszerkutato Intezet Sposob poluchenija novykh soedinenij s ehrgolenovymi i
JPS577172Y2 (enExample) * 1977-03-17 1982-02-10
JPS582957U (ja) * 1981-06-30 1983-01-10 松下電子工業株式会社 高圧ナトリウムランプ
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
DD238051A1 (de) * 1985-06-10 1986-08-06 Dresden Arzneimittel Verfahren zur herstellung neuer lysergsaeureamide
SG181896A1 (en) * 2009-12-23 2012-07-30 Map Pharmaceuticals Inc Novel ergoline analogs
WO2012177962A1 (en) 2011-06-23 2012-12-27 Map Pharmaceuticals, Inc. Novel fluoroergoline analogs
AU2012355982A1 (en) 2011-12-19 2014-07-10 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
WO2013095708A1 (en) 2011-12-21 2013-06-27 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
BR112017015487A2 (pt) * 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
WO2018223065A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533699A (en) * 1950-12-12 Amines containing the king system
US2673850A (en) * 1951-07-28 1954-03-30 Sandoz Ag Piperazides of the lysergic acid series
US2946796A (en) * 1958-10-15 1960-07-26 Grace W R & Co Salts of ergot alkaloids
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
US3901893A (en) * 1970-05-18 1975-08-26 Richter Gedeon Vegyeszet New dihydro-lysergic acid derivative
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation

Also Published As

Publication number Publication date
BE829518A (fr) 1975-09-15
DK143801B (da) 1981-10-12
FR2272671B1 (enExample) 1978-10-06
GB1474337A (en) 1977-05-25
PL98944B1 (pl) 1978-05-31
DK143801C (da) 1982-03-22
ES437994A1 (es) 1977-01-16
FI751537A7 (enExample) 1975-11-29
FR2272671A1 (enExample) 1975-12-26
ATA386375A (de) 1978-03-15
FI61897C (fi) 1982-10-11
IL47361A (en) 1979-11-30
JPS516998A (enExample) 1976-01-20
AT346501B (de) 1978-11-10
IL47361A0 (en) 1975-07-28
SU625612A3 (ru) 1978-09-25
DE2523743A1 (de) 1975-12-18
DK235175A (da) 1975-11-29
JPS5218718B2 (enExample) 1977-05-24
CS194227B2 (en) 1979-11-30
DD121639A5 (enExample) 1976-08-12
AU8142575A (en) 1976-11-25
CA1051878A (en) 1979-04-03
NL7506276A (nl) 1975-12-02
US4005089A (en) 1977-01-25
YU135575A (en) 1982-06-30
SE419548B (sv) 1981-08-10
BG27374A3 (bg) 1979-10-12
SE7505974L (sv) 1975-12-01
FI61897B (fi) 1982-06-30

Similar Documents

Publication Publication Date Title
FR2272671B1 (enExample)
AU495883B2 (enExample)
AU7459574A (enExample)
AU495844B2 (enExample)
AU485022B2 (enExample)
AU7253574A (enExample)
AU7099174A (enExample)
AR197698Q (enExample)
AU480463A (enExample)
AU479523A (enExample)
AU480069A (enExample)
AU480659A (enExample)
AU480723A (enExample)
AU480758A (enExample)
AU480994A (enExample)
AU481119A (enExample)
AU481197A (enExample)
AU481296A (enExample)
AU479969A (enExample)
AU481898A (enExample)
AU482149A (enExample)
AU482286A (enExample)
AU479802A (enExample)
AU479758A (enExample)
AU479725A (enExample)